Altria
MO
$67.15
+3.02%
Altria Group, Inc. is a leading tobacco company in the United States, operating through subsidiaries that manufacture and sell cigarettes, smokeless tobacco, and cigars, with its flagship Marlboro brand holding a dominant 40% market share. The company is a mature market leader in a declining industry, distinct for its immense cash generation and shareholder returns, while also holding strategic investments in Anheuser-Busch InBev and Cronos Group. The current investor narrative is dominated by its high-yield dividend appeal and valuation debate, juxtaposed against the secular decline of its core combustible products and the uncertain progress of its reduced-risk portfolio, including its NJOY vaping acquisition and heated tobacco joint venture, as it navigates a challenging long-term transition.…
MO
Altria
$67.15
Related headlines
MO 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Altria's 12-month outlook, with a consensus price target around $87.30 and implied upside of +30.0% versus the current price.
Average Target
$87.30
6 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
6
covering this stock
Price Range
$54 - $87
Analyst target range
Analyst coverage for Altria is limited, with only 6 analysts providing estimates, indicating it is a well-known but mature company with less frequent research updates. The available data shows consensus estimates for EPS and revenue but does not provide a consensus price target, Buy/Hold/Sell distribution, or a target price range, which is atypical for a large-cap stock and suggests analyst sentiment is not being aggregated into a clear price forecast. The lack of explicit price targets implies that investment theses are likely built on dividend yield and valuation metrics rather than price appreciation catalysts, and the limited number of analysts can lead to higher volatility and less efficient price discovery as news and earnings are interpreted by a smaller pool of institutional voices.
MO Technical Analysis
The stock is in a pronounced downtrend, having declined 1.35% over the past six months, and is currently trading near the lower end of its 52-week range, at approximately 91% of the distance from its 52-week high of $70.51 to its low of $54.70, indicating significant pressure and positioning it closer to a potential value zone than a momentum peak. Recent short-term momentum shows a modest recovery attempt, with a 3.90% gain over the last three months, but this is overshadowed by a 1.47% loss over the past month, suggesting the rally has stalled and the stock remains vulnerable to further weakness. Key technical support is clearly defined at the 52-week low of $54.70, while resistance sits at the recent high of $70.51; a sustained breakdown below support would signal a continuation of the bearish trend, whereas the stock's low beta of 0.447 indicates it has been significantly less volatile than the broader market, which may appeal to defensive, income-focused investors despite the price weakness.
Beta
0.45
0.45x market volatility
Max Drawdown
-19.1%
Largest decline past year
52-Week Range
$55-$71
Price range past year
Annual Return
+14.7%
Cumulative gain past year
| Period | MO Return | S&P 500 |
|---|---|---|
| 1m | +4.4% | +8.5% |
| 3m | +8.5% | +2.8% |
| 6m | +3.8% | +4.6% |
| 1y | +14.7% | +32.3% |
| ytd | +17.2% | +3.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MO Fundamental Analysis
Revenue growth is volatile and currently decelerating, with Q4 2025 revenue of $5.85 billion representing a 14.5% year-over-year increase, but this follows a sharp sequential drop from Q3's $5.25 billion, and segment data shows the core Smokeable Products segment ($5.12B) still dominates, highlighting the company's dependence on a declining business. Profitability remains robust on a gross margin basis at 62.1% for Q4, but net income of $1.12 billion was down significantly from $2.38 billion in the prior quarter, indicating margin compression and earnings volatility, though the trailing twelve-month net margin is a healthy 34.5%. The balance sheet shows significant financial leverage with a negative debt-to-equity ratio of -7.34, a common artifact for companies with negative book equity, but it generates substantial cash, with free cash flow over the trailing twelve months of $9.07 billion, providing ample coverage for its generous dividend, which is underscored by a payout ratio of 100.2%.
Quarterly Revenue
$5.8B
2025-12
Revenue YoY Growth
+0.14%
YoY Comparison
Gross Margin
+0.62%
Latest Quarter
Free Cash Flow
$9.1B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MO Overvalued?
Given the company's positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE is 13.9x, while the forward PE is lower at 11.0x, indicating the market expects earnings growth or a stabilization in profitability in the coming year. Compared to its own historical range, the current trailing PE of 13.9x sits below the multi-year highs seen in recent quarters (e.g., 23.5x in Q1 2025) and is near the lower end of its historical spectrum, suggesting the stock is trading at a relatively discounted multiple based on its own history, which may reflect pessimism around long-term earnings sustainability. A direct industry average comparison is not available in the provided data, but the discounted forward multiple implies the market is pricing in significant challenges, potentially offering a margin of safety if the dividend remains secure and the transition to reduced-risk products gains traction.
PE
13.9x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -8x~81x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
10.9x
Enterprise Value Multiple

